Literature DB >> 22409875

Phase composition and in vitro bioactivity of porous implants made of bioactive glass S53P4.

S Fagerlund1, J Massera, N Moritz, L Hupa, M Hupa.   

Abstract

This work studied the influence of sintering temperature on the phase composition, compression strength and in vitro properties of implants made of bioactive glass S53P4. The implants were sintered within the temperature range 600-1000°C. Over the whole temperature range studied, consolidation took place mainly via viscous flow sintering, even though there was partial surface crystallization. The mechanical strength of the implants was low but increased with the sintering temperature, from 0.7 MPa at 635°C to 10 MPa at 1000°C. Changes in the composition of simulated body fluid (SBF), the immersion solution, were evaluated by pH measurements and ion analysis using inductively coupled plasma optical emission spectrometry. The development of a calcium phosphate layer on the implant surfaces was verified using scanning electron microscopy-electron-dispersive X-ray analysis. When immersed in SBF, a calcium phosphate layer formed on all the samples, but the structure of this layer was affected by the surface crystalline phases. Hydroxyapatite formed more readily on amorphous and partially crystalline implants containing both primary Na(2)O·CaO·2SiO(2) and secondary Na(2)Ca(4)(PO(4))(2)SiO(4) crystals than on implants containing only primary crystals.
Copyright © 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22409875     DOI: 10.1016/j.actbio.2012.03.011

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  3 in total

1.  Influence of SrO substitution for CaO on the properties of bioactive glass S53P4.

Authors:  Jonathan Massera; Leena Hupa
Journal:  J Mater Sci Mater Med       Date:  2013-12-12       Impact factor: 3.896

2.  In Vitro Degradation of Borosilicate Bioactive Glass and Poly(l-lactide-co-ε-caprolactone) Composite Scaffolds.

Authors:  Jenna Tainio; Kaarlo Paakinaho; Niina Ahola; Markus Hannula; Jari Hyttinen; Minna Kellomäki; Jonathan Massera
Journal:  Materials (Basel)       Date:  2017-11-06       Impact factor: 3.623

3.  In vitro Evaluation of Porous borosilicate, borophosphate and phosphate Bioactive Glasses Scaffolds fabricated using Foaming Agent for Bone Regeneration.

Authors:  E P Erasmus; R Sule; O T Johnson; J Massera; I Sigalas
Journal:  Sci Rep       Date:  2018-02-27       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.